July 2015: Two Australian scientists, including an Emeritus Professor at the Australian National University and a neuroscientist from the Garvan Institute, have published a new review article for neurologists on TNF. The article discusses the science of TNF, its physiology and the scientific rationale for perispinal etanercept for treatment of post-stroke neurological dysfunction and other brain disorders.
The article is open access, so the INR PLLC has made it freely downloadable by double-clicking on the links provided, so that readers may read this at home, or send the article to their neurologist, physicians, or family members.
Clark, I.A. and Bryce Vissel, A Neurologist’s Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease. Neural Plasticity, 2015, Article ID 358263.http://dx.doi.org/10.1155/2015/358263 . FREE FULL-TEXT.
“The New Stroke Treatment That’s Changing Lives”
Sunday Night (Australia), March 29, 2015
On March 29, 2015 the television news program “Sunday Night” in Australia aired a national news feature story about INR’s perispinal etanercept stroke treatment. The story was entitled “The New Stroke Treatment That’s Changing Lives”, and it is accessible online at the link:
https://au.news.yahoo.com/sunday-night/features/a/26856981/the-new-stroke-treatment-thats-changing-lives/
Sunday Night “The New Stroke Treatment That’s Changing Lives”.
In the television feature, the clinical results of two patients treated at the INR by INR Los Angeles medical director Nancy Kim M.D., are depicted. The story was filmed both in Los Angeles at the time of treatment and in Australia, after each of the patients returned home.
Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. Treatment for this indication is off-label. Please see the Terms of Use. The method of treatment utilized is a patented invention of the INR. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8900583 all assigned to TACT IP, LLC; and Australian patent 758523.
Patient from Oklahoma is able to run minutes after treatment by Edward Tobinick MD at the INR two years after stroke!
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2016 INR PLLC, all rights reserved.
Traumatic Brain Injury 8 years prior, gait improvement after treatment at the INR in Boca Raton in March 2017.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2017 INR PLLC, all rights reserved.
Scientific literature provides support for the scientific rationale. See: